Trastuzumab, paclitaxel, cisplatin, and radiation for adenocarcinoma of the esophagus: a phase I study.
Safran H, DiPetrillo T, Nadeem A, Steinhoff M, Tantravahi U, Rathore R, Wanebo H, Hughes M, Maia C, Tsai JY, Pasquariello T, Pepperell JR, Cioffi W, Kennedy T, Reeder L, Ng T, Adrian A, Goldstein L, Chak B, Choy H.
Safran H, et al.
Cancer Invest. 2004;22(5):670-7. doi: 10.1081/cnv-200032951.
Cancer Invest. 2004.
PMID: 15581047
Clinical Trial.